RxDoctor Payments Data

Christopher de Jesus, MD

Colon & Rectal Surgery · San Antonio, TXNPI 1184019374

Payments from drug & device makers

What this record shows

This record is dominated by education: $176,623 of the $200,620 with a category attached, or 88.0%. Intuitive Surgical accounts for 99.3% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2024 at $105,084 and has fallen 76.5% since, to $24,731 in 2025. Among colon & rectal surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$200,620in general payments, 2019–2025

Across 205 payments — averaging $978.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$199K
  • Medtronic$370
  • Intercept Pharmaceuticals, Inc.$174
  • Kerecis Limited$156
  • Solventum Corporation$144
  • Checkpoint Surgical, Inc$100
  • plus $549 from 14 others

What the payments were for

  • Speaking & faculty fees$4,0002%
  • Travel & lodging$7,5764%
  • Food & beverage$12,4076%
  • Education$176,62388%
  • Gifts$140%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$200,620 in reported general payments places this provider in the 95th percentile of 200 colon & rectal surgery providers in Texas.

See all colon & rectal surgery providers in Texas

Medicare billing

Part B allowed, 2024
$26,745
Medicare patients
47
Services billed
98

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl14$233
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl12$179

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →